(KTB) Kontoor Brands - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US50050N1037
Stock: Apparel, Footwear, Accessories, Denim
Total Rating 45
Risk 72
Buy Signal -0.86
| Risk 5d forecast | |
|---|---|
| Volatility | 56.1% |
| Relative Tail Risk | -13.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | -8.27 |
| Character TTM | |
|---|---|
| Beta | 1.411 |
| Beta Downside | 1.648 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.92% |
| CAGR/Max DD | 0.31 |
EPS (Earnings per Share)
Revenue
Description: KTB Kontoor Brands March 04, 2026
Kontoor Brands Inc. (KTB) is a lifestyle apparel company that designs, produces, and distributes denim, apparel, footwear, and accessories. The company operates globally, with significant presence in the Americas, Europe, and Asia-Pacific regions.
KTBs core business revolves around its two primary segments: Wrangler and Lee. These brands are well-established in the denim and casual wear market, a mature segment within the broader apparel industry. The company also licenses the Rock & Republic brand.
KTB employs a diversified distribution strategy, selling products through mass merchants, specialty stores, department stores, company-operated stores, and e-commerce platforms. This multi-channel approach is common for apparel companies seeking broad market penetration.
For more detailed financial analysis and performance metrics, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Wrangler and Lee brand strength drives revenue growth
- Cotton prices impact manufacturing costs and margins
- Global supply chain disruptions affect product availability
- Consumer discretionary spending influences apparel demand
- E-commerce expansion boosts direct-to-consumer sales
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 227.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -4.32 > 1.0 |
| NWC/Revenue: 15.46% < 20% (prev 25.71%; Δ -10.25% < -1%) |
| CFO/TA 0.18 > 3% & CFO 455.8m > Net Income 227.5m |
| Net Debt (1.19b) to EBITDA (430.6m): 2.75 < 3 |
| Current Ratio: 1.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.3m) vs 12m ago 0.52% < -2% |
| Gross Margin: 46.58% > 18% (prev 0.45%; Δ 4.61k % > 0.5%) |
| Asset Turnover: 149.0% > 50% (prev 158.0%; Δ -9.01% > 0%) |
| Interest Coverage Ratio: 6.19 > 6 (EBITDA TTM 430.6m / Interest Expense TTM 61.8m) |
Altman Z'' 2.91
| A: 0.19 (Total Current Assets 1.08b - Total Current Liabilities 593.6m) / Total Assets 2.58b |
| B: 0.11 (Retained Earnings 274.3m / Total Assets 2.58b) |
| C: 0.18 (EBIT TTM 382.8m / Avg Total Assets 2.12b) |
| D: 0.10 (Book Value of Equity 206.7m / Total Liabilities 2.02b) |
| Altman-Z'' Score: 2.91 = A |
Beneish M -2.63
| DSRI: 0.88 (Receivables 276.4m/260.2m, Revenue 3.15b/2.61b) |
| GMI: 0.96 (GM 46.58% / 44.55%) |
| AQI: 1.80 (AQ_t 0.48 / AQ_t-1 0.26) |
| SGI: 1.21 (Revenue 3.15b / 2.61b) |
| TATA: -0.09 (NI 227.5m - CFO 455.8m) / TA 2.58b) |
| Beneish M-Score: -2.63 (Cap -4..+1) = A |
What is the price of KTB shares?
As of March 12, 2026, the stock is trading at USD 68.06 with a total of 1,047,906 shares traded.
Over the past week, the price has changed by -14.34%, over one month by -0.79%, over three months by -1.94% and over the past year by +13.66%.
Over the past week, the price has changed by -14.34%, over one month by -0.79%, over three months by -1.94% and over the past year by +13.66%.
Is KTB a buy, sell or hold?
Kontoor Brands has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold KTB.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KTB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92.7 | 36.2% |
| Analysts Target Price | 92.7 | 36.2% |
KTB Fundamental Data Overview March 10, 2026
P/E Trailing = 19.6572
P/E Forward = 12.1065
P/S = 1.345
P/B = 8.006
Revenue TTM = 3.15b USD
EBIT TTM = 382.8m USD
EBITDA TTM = 430.6m USD
Long Term Debt = 1.34b USD (from longTermDebt, two quarters ago)
Short Term Debt = 42.4m USD (from shortTermDebt, last quarter)
Debt = 1.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 5.43b USD (4.24b + Debt 1.29b - CCE 108.4m)
Interest Coverage Ratio = 6.19 (Ebit TTM 382.8m / Interest Expense TTM 61.8m)
EV/FCF = 12.52x (Enterprise Value 5.43b / FCF TTM 433.3m)
FCF Yield = 7.99% (FCF TTM 433.3m / Enterprise Value 5.43b)
FCF Margin = 13.74% (FCF TTM 433.3m / Revenue TTM 3.15b)
Net Margin = 7.21% (Net Income TTM 227.5m / Revenue TTM 3.15b)
Gross Margin = 46.58% ((Revenue TTM 3.15b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 46.90% (prev 45.78%)
Tobins Q-Ratio = 2.10 (Enterprise Value 5.43b / Total Assets 2.58b)
Interest Expense / Debt = 1.54% (Interest Expense 19.9m / Debt 1.29b)
Taxrate = 27.56% (28.1m / 101.8m)
NOPAT = 277.3m (EBIT 382.8m * (1 - 27.56%))
Current Ratio = 1.82 (Total Current Assets 1.08b / Total Current Liabilities 593.6m)
Debt / Equity = 2.29 (Debt 1.29b / totalStockholderEquity, last quarter 564.9m)
Debt / EBITDA = 2.75 (Net Debt 1.19b / EBITDA 430.6m)
Debt / FCF = 2.74 (Net Debt 1.19b / FCF TTM 433.3m)
Total Stockholder Equity = 504.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.75% (Net Income 227.5m / Total Assets 2.58b)
RoE = 45.05% (Net Income TTM 227.5m / Total Stockholder Equity 504.9m)
RoCE = 20.72% (EBIT 382.8m / Capital Employed (Equity 504.9m + L.T.Debt 1.34b))
RoIC = 16.98% (NOPAT 277.3m / Invested Capital 1.63b)
WACC = 8.78% (E(4.24b)/V(5.53b) * Re(11.12%) + D(1.29b)/V(5.53b) * Rd(1.54%) * (1-Tc(0.28)))
Discount Rate = 11.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.58%
[DCF] Terminal Value 75.48% ; FCFF base≈399.2m ; Y1≈404.2m ; Y5≈438.8m
[DCF] Fair Price = 98.80 (EV 6.68b - Net Debt 1.19b = Equity 5.49b / Shares 55.6m; r=8.78% [WACC]; 5y FCF grow 0.93% → 2.90% )
EPS Correlation: 46.64 | EPS CAGR: 5.81% | SUE: 0.59 | # QB: 0
Revenue Correlation: 52.17 | Revenue CAGR: 11.40% | SUE: 1.70 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.18 | Chg7d=+0.001 | Chg30d=-0.001 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=6.48 | Chg7d=+0.515 | Chg30d=+0.497 | Revisions Net=-3 | Growth EPS=+15.9% | Growth Revenue=+9.3%
EPS next Year (2027-12-31): EPS=7.01 | Chg7d=+0.392 | Chg30d=+0.374 | Revisions Net=+4 | Growth EPS=+8.2% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 11.1% - Earnings Yield 5.1%)
[Growth] Growth Spread = +12.2% (Analyst 18.3% - Implied 6.0%)
P/E Forward = 12.1065
P/S = 1.345
P/B = 8.006
Revenue TTM = 3.15b USD
EBIT TTM = 382.8m USD
EBITDA TTM = 430.6m USD
Long Term Debt = 1.34b USD (from longTermDebt, two quarters ago)
Short Term Debt = 42.4m USD (from shortTermDebt, last quarter)
Debt = 1.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 5.43b USD (4.24b + Debt 1.29b - CCE 108.4m)
Interest Coverage Ratio = 6.19 (Ebit TTM 382.8m / Interest Expense TTM 61.8m)
EV/FCF = 12.52x (Enterprise Value 5.43b / FCF TTM 433.3m)
FCF Yield = 7.99% (FCF TTM 433.3m / Enterprise Value 5.43b)
FCF Margin = 13.74% (FCF TTM 433.3m / Revenue TTM 3.15b)
Net Margin = 7.21% (Net Income TTM 227.5m / Revenue TTM 3.15b)
Gross Margin = 46.58% ((Revenue TTM 3.15b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 46.90% (prev 45.78%)
Tobins Q-Ratio = 2.10 (Enterprise Value 5.43b / Total Assets 2.58b)
Interest Expense / Debt = 1.54% (Interest Expense 19.9m / Debt 1.29b)
Taxrate = 27.56% (28.1m / 101.8m)
NOPAT = 277.3m (EBIT 382.8m * (1 - 27.56%))
Current Ratio = 1.82 (Total Current Assets 1.08b / Total Current Liabilities 593.6m)
Debt / Equity = 2.29 (Debt 1.29b / totalStockholderEquity, last quarter 564.9m)
Debt / EBITDA = 2.75 (Net Debt 1.19b / EBITDA 430.6m)
Debt / FCF = 2.74 (Net Debt 1.19b / FCF TTM 433.3m)
Total Stockholder Equity = 504.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.75% (Net Income 227.5m / Total Assets 2.58b)
RoE = 45.05% (Net Income TTM 227.5m / Total Stockholder Equity 504.9m)
RoCE = 20.72% (EBIT 382.8m / Capital Employed (Equity 504.9m + L.T.Debt 1.34b))
RoIC = 16.98% (NOPAT 277.3m / Invested Capital 1.63b)
WACC = 8.78% (E(4.24b)/V(5.53b) * Re(11.12%) + D(1.29b)/V(5.53b) * Rd(1.54%) * (1-Tc(0.28)))
Discount Rate = 11.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.58%
[DCF] Terminal Value 75.48% ; FCFF base≈399.2m ; Y1≈404.2m ; Y5≈438.8m
[DCF] Fair Price = 98.80 (EV 6.68b - Net Debt 1.19b = Equity 5.49b / Shares 55.6m; r=8.78% [WACC]; 5y FCF grow 0.93% → 2.90% )
EPS Correlation: 46.64 | EPS CAGR: 5.81% | SUE: 0.59 | # QB: 0
Revenue Correlation: 52.17 | Revenue CAGR: 11.40% | SUE: 1.70 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.18 | Chg7d=+0.001 | Chg30d=-0.001 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=6.48 | Chg7d=+0.515 | Chg30d=+0.497 | Revisions Net=-3 | Growth EPS=+15.9% | Growth Revenue=+9.3%
EPS next Year (2027-12-31): EPS=7.01 | Chg7d=+0.392 | Chg30d=+0.374 | Revisions Net=+4 | Growth EPS=+8.2% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 11.1% - Earnings Yield 5.1%)
[Growth] Growth Spread = +12.2% (Analyst 18.3% - Implied 6.0%)